IL99628A - Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them - Google Patents

Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them

Info

Publication number
IL99628A
IL99628A IL9962891A IL9962891A IL99628A IL 99628 A IL99628 A IL 99628A IL 9962891 A IL9962891 A IL 9962891A IL 9962891 A IL9962891 A IL 9962891A IL 99628 A IL99628 A IL 99628A
Authority
IL
Israel
Prior art keywords
formula
compound
group
amino acid
give
Prior art date
Application number
IL9962891A
Other languages
English (en)
Other versions
IL99628A0 (en
Inventor
Chaim Gilon
Zvi Zelinger
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Priority to IL9962891A priority Critical patent/IL99628A/en
Publication of IL99628A0 publication Critical patent/IL99628A0/xx
Priority to AT92309016T priority patent/ATE189228T1/de
Priority to JP30434792A priority patent/JP3509029B2/ja
Priority to EP92309016A priority patent/EP0564739B1/en
Priority to DE69230610T priority patent/DE69230610T2/de
Priority to US08/444,135 priority patent/US5723575A/en
Priority to US08/569,042 priority patent/US6117974A/en
Publication of IL99628A publication Critical patent/IL99628A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL9962891A 1991-10-02 1991-10-02 Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them IL99628A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL9962891A IL99628A (en) 1991-10-02 1991-10-02 Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them
AT92309016T ATE189228T1 (de) 1991-10-02 1992-10-02 Peptide mit zyklischen hauptketten, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
JP30434792A JP3509029B2 (ja) 1991-10-02 1992-10-02 生物活性環化ポリペプチド
EP92309016A EP0564739B1 (en) 1991-10-02 1992-10-02 Backbone cyclic peptides, processes for their preparation and pharmaceutical compositions containing them
DE69230610T DE69230610T2 (de) 1991-10-02 1992-10-02 Peptide mit zyklischen Hauptketten, deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US08/444,135 US5723575A (en) 1991-10-02 1995-05-18 Process for the preparation of backbone cyclic peptides
US08/569,042 US6117974A (en) 1991-10-02 1995-12-07 Libraries of backbone-cyclized peptidomimetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL9962891A IL99628A (en) 1991-10-02 1991-10-02 Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
IL99628A0 IL99628A0 (en) 1992-08-18
IL99628A true IL99628A (en) 2004-07-25

Family

ID=11062920

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9962891A IL99628A (en) 1991-10-02 1991-10-02 Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them

Country Status (6)

Country Link
US (1) US5723575A (ar)
EP (1) EP0564739B1 (ar)
JP (1) JP3509029B2 (ar)
AT (1) ATE189228T1 (ar)
DE (1) DE69230610T2 (ar)
IL (1) IL99628A (ar)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117974A (en) * 1991-10-02 2000-09-12 Peptor Limited Libraries of backbone-cyclized peptidomimetics
US6872803B1 (en) 1993-09-21 2005-03-29 Kyowa Hakko Kogyo Co., Ltd. Peptides
US6407059B1 (en) 1994-06-08 2002-06-18 Peptor Limited Conformationally constrained backbone cyclized peptide analogs
AU724386B2 (en) * 1994-06-08 2000-09-21 Peptor Ltd Conformationally constrained backbone cyclized peptide analogs
IL109943A (en) * 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
US6051554A (en) * 1995-06-07 2000-04-18 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US6841533B1 (en) 1995-12-07 2005-01-11 Peptor Limited Conformationally constrained backbone cyclized interleukin-6 antagonists
US6117641A (en) 1996-04-11 2000-09-12 Mitotix, Inc. Assays and reagents for identifying anti-fungal agents and uses related thereto
US6727082B1 (en) 1996-04-11 2004-04-27 Gpc Biotech Inc. Assays and reagents for identifying anti-fungal agents, and uses related thereto
CA2251593A1 (en) 1996-04-11 1997-10-16 Mitotix, Inc. Assays and reagents for identifying anti-fungal agents, and uses related thereto
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
IL122343A0 (en) * 1997-11-27 1998-04-05 Yissum Res Dev Co Inhibition of nuclear import by backbone cyclic peptide analogs
AU1254299A (en) * 1997-12-02 1999-06-16 State Of Israel - Ministry Of Agriculture Backbone cyclic peptide fragments and their analogs derived from pban 1-33, use ful as insecticides
AU2053699A (en) 1997-12-15 1999-07-05 Peptor Ltd. Branched building units for synthesizing cyclic peptides
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
WO2002014537A2 (en) * 2000-08-14 2002-02-21 Fallon Joan M Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
EP1468013A4 (en) * 2002-01-03 2005-03-16 Yissum Res Dev Co CYCLIC PEPTIDES WITH CARBON SKELETON HAVING RESTRICTED CONFORMATION
US20030144260A1 (en) * 2002-01-03 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Heterocyclic compounds, method of developing new drug leads and combinatorial libraries used in such method
IL148921A0 (en) * 2002-03-26 2002-09-12 Peptor Ltd Photo active backbone cyclized somatostatin analogs for optical imaging and photodynamic therapy
US6987167B2 (en) * 2002-05-22 2006-01-17 Wockhardt Limited Process for production of the somatostatin analog, octreotide
IL150384A0 (en) * 2002-06-24 2002-12-01 Peptor Ltd Radiolabelled somatostatin analogs backbone cyclized through metal complexation
US20060211507A1 (en) * 2005-03-21 2006-09-21 Intertex, Inc. Stake for securing inflatable devices
KR20080027246A (ko) * 2005-05-31 2008-03-26 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 기본구조에 고리가 형성된 멜라노코르틴 자극 호르몬유사체
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
WO2010002972A1 (en) 2008-07-01 2010-01-07 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
BRPI1007378A2 (pt) 2009-01-06 2020-08-18 Curemark Llc composições e métodos para o tratamento ou prevenção de infecções por staphylococcus aureus e para a erradicação ou redução de staphylococcus aureus sobre superfícies.
EP2947100B1 (en) 2009-01-06 2019-05-08 Galenagen, LLC Oral compositions for the treatment or the prevention of infections by E. Coli
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
HUE050873T2 (hu) 2011-04-21 2021-01-28 Curemark Llc Vegyületek neuropszichiátriai rendellenességek kezelésére
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE150199C (ar) *
FR2611722B1 (fr) * 1987-03-02 1989-08-11 Inst Nat Sante Rech Med Nouveaux peptides derives de la cck8, leur preparation et les compositions pharmaceutiques qui les contiennent
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
CA2036973A1 (en) * 1990-02-27 1991-08-28 Mark G. Bock Cyclic hexapeptide oxytocin antagonists
US5169935A (en) * 1990-06-20 1992-12-08 The Salk Institute For Biological Studies Method of making peptides

Also Published As

Publication number Publication date
DE69230610D1 (de) 2000-03-02
EP0564739B1 (en) 2000-01-26
EP0564739A3 (ar) 1995-04-26
IL99628A0 (en) 1992-08-18
US5723575A (en) 1998-03-03
ATE189228T1 (de) 2000-02-15
DE69230610T2 (de) 2000-12-28
JP3509029B2 (ja) 2004-03-22
JPH06263797A (ja) 1994-09-20
EP0564739A2 (en) 1993-10-13

Similar Documents

Publication Publication Date Title
IL99628A (en) Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them
FI91075C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten peptidien valmistamiseksi
US7589170B1 (en) Synthesis of cyclic peptides
US4737487A (en) VIP type peptides
EP0674652B1 (en) Dolastatin analog
US20110160147A1 (en) Novel dual targeting antitumoral conjugates
JPH07121956B2 (ja) ブラジキニンアンタゴニスト作用を有するペプチド
KR20010022924A (ko) 페네틸아민 유도체
US6235876B1 (en) Liquid phase process for the preparation of GNRH peptides
KR100286242B1 (ko) 돌라스타틴 유도체
AU759442B2 (en) Novel LHRH antagonists with improved solubility characteristics
US20060247157A1 (en) Methods for making intermediates and oxytocin analogues
US20040122013A1 (en) Analogs of nocicettin
EP2662087A1 (en) Somatostatin vectors
CA1157466A (en) Peptides having thymopoietin-like activity
AU660809B2 (en) New peptide compounds having bradykinin-antagonist activity, process for their preparation and the pharmaceutical compositions which contain them
PT98498A (pt) Processo para a preparacao de polipeptidos e de composicoes farmaceuticas que os contem
WO1991006563A1 (en) Reduced irreversible bombesin antagonists
WO1986003495A2 (en) Derivatives of substances p and of fragments thereof
BERNIER et al. Conformation of physalaemin
EP1348714B1 (en) Polypeptide useful as anti-allergic/antiasthmatic, methods for the preparation thereof and pharmaceutical compositions containing such polypeptide and their use
JPH10500404A (ja) 混合したμアゴニスト／δアンタゴニストの性質を有する新規なオピオイドペプチド類似体
US20060160989A1 (en) Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereof
AU766495B2 (en) Synthesis of cyclic peptides
JPS59101450A (ja) ペプチド

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees